Trevi Therapeutics Inc. Shares Close the Day 10.0% Lower - Daily Wrap
The company saw its shares close the day 10.0% lower than yesterday, with trading volume lower than its 30 day average.
Mar 23, 2021 by Kwhen Finance Editors
Trevi Therapeutics Inc. shares closed today 10.0% lower than it did at the end of yesterday. The stock is currently up 19.8% year-to-date, up 22.9% over the past 12 months, and down 63.2% over the past five years. Today, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 fell 0.5%.
Trading Activity
- Shares traded as high as $2.96 and as low as $2.53 this week.
- Shares closed 7e+1% below its 52-week high and 1e+2% above its 52-week low.
- Trading volume this week was 61.6% higher than the 10-day average and 31.6% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Trevi Therapeutics Inc. | -10.0 | 19.8 | 22.9 | ||
| Dow Jones Industrial Average | 0.0 | 6.4 | 77.6 | -2.1 | 61.6 |
| S&P 500 Index | -0.5 | 4.5 | 77.5 | -1.5 | 65.7 |
| Health Care | -0.4 | 1.2 | 58.4 | -3.9 | 49.3 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -273.2%
- The company's stock price performance over the past 12 months beats the peer average by -1438.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Trevi Therapeutics Inc. | TRVI | 0 | 19.8 | 22.9 | ||
| Peer Avg | N/A | -2.2 | -11.4 | -1.7 | ||
| Omeros Corporation | OMER | -8.8 | 37.1 | 78.6 | ||
| Odonate Therapeutics Inc. | ODT | 0 | -82.9 | -85.5 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: